SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Jukonen J)
 

Sökning: WFRF:(Jukonen J) > (2021) > Aggressive and recu...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003065naa a2200409 4500
001oai:prod.swepub.kib.ki.se:146600831
003SwePub
008240701s2021 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1466008312 URI
024a https://doi.org/10.1038/s41598-021-88382-62 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Jukonen, J4 aut
2451 0a Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality
264 c 2021-04-23
264 1b Springer Science and Business Media LLC,c 2021
520 a Erythropoietin producing hepatocellular (Eph) receptors and their membrane-bound ligands ephrins are variably expressed in epithelial cancers, with context-dependent implications to both tumor-promoting and -suppressive processes in ways that remain incompletely understood. Using ovarian cancer tissue microarrays and longitudinally collected patient cells, we show here that ephrinA5/EFNA5 is specifically overexpressed in the most aggressive high-grade serous carcinoma (HGSC) subtype, and increased in the HGSC cells upon disease progression. Among all the eight ephrin genes, high EFNA5 expression was most strongly associated with poor overall survival in HGSC patients from multiple independent datasets. In contrast, high EFNA3 predicted improved overall and progression-free survival in The Cancer Genome Atlas HGSC dataset, as expected for a canonical inducer of tumor-suppressive Eph receptor tyrosine kinase signaling. While depletion of either EFNA5 or the more extensively studied, canonically acting EFNA1 in HGSC cells increased the oncogenic EphA2-S897 phosphorylation, EFNA5 depletion left unaltered, or even increased the ligand-dependent EphA2-Y588 phosphorylation. Moreover, treatment with recombinant ephrinA5 led to limited EphA2 tyrosine phosphorylation, internalization and degradation compared to ephrinA1. Altogether, our results suggest a unique function for ephrinA5 in Eph-ephrin signaling and highlight the clinical potential of ephrinA5 as a cell surface biomarker in the most aggressive HGSCs.
700a Moyano-Galceran, Lu Karolinska Institutet4 aut
700a Hopfner, K4 aut
700a Pietila, EA4 aut
700a Lehtinen, L4 aut
700a Huhtinen, K4 aut
700a Gucciardo, E4 aut
700a Hynninen, J4 aut
700a Hietanen, S4 aut
700a Grenman, S4 aut
700a Ojala, PM4 aut
700a Carpen, O4 aut
700a Lehti, Ku Karolinska Institutet4 aut
710a Karolinska Institutet4 org
773t Scientific reportsd : Springer Science and Business Media LLCg 11:1, s. 8856-q 11:1<8856-x 2045-2322
856u https://www.nature.com/articles/s41598-021-88382-6.pdf
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:146600831
8564 8u https://doi.org/10.1038/s41598-021-88382-6

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy